- Home
- BRT vs SMTI Comparison
BRT vs SMTI Comparison
Compare BRT & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRT
- SMTI
- Stock Information
- Founded
- BRT 1972
- SMTI 1982
- Country
- BRT United States
- SMTI United States
- Employees
- BRT N/A
- SMTI N/A
- Industry
- BRT Real Estate Investment Trusts
- SMTI Medical/Dental Instruments
- Sector
- BRT Real Estate
- SMTI Health Care
- Exchange
- BRT Nasdaq
- SMTI Nasdaq
- Market Cap
- BRT 281.9M
- SMTI 251.6M
- IPO Year
- BRT N/A
- SMTI N/A
- Fundamental
- Price
- BRT $14.64
- SMTI $27.56
- Analyst Decision
- BRT Strong Buy
- SMTI Strong Buy
- Analyst Count
- BRT 1
- SMTI 2
- Target Price
- BRT $19.50
- SMTI $50.00
- AVG Volume (30 Days)
- BRT 46.2K
- SMTI 26.3K
- Earning Date
- BRT 11-06-2025
- SMTI 11-12-2025
- Dividend Yield
- BRT 6.83%
- SMTI N/A
- EPS Growth
- BRT N/A
- SMTI N/A
- EPS
- BRT N/A
- SMTI N/A
- Revenue
- BRT $98,350,000.00
- SMTI $97,241,894.00
- Revenue This Year
- BRT N/A
- SMTI $24.49
- Revenue Next Year
- BRT $4.12
- SMTI $14.43
- P/E Ratio
- BRT N/A
- SMTI N/A
- Revenue Growth
- BRT 2.71
- SMTI 34.29
- 52 Week Low
- BRT $14.17
- SMTI $23.53
- 52 Week High
- BRT $20.22
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- BRT 41.45
- SMTI 39.69
- Support Level
- BRT $14.41
- SMTI $26.26
- Resistance Level
- BRT $15.09
- SMTI $28.56
- Average True Range (ATR)
- BRT 0.35
- SMTI 1.25
- MACD
- BRT 0.03
- SMTI -0.17
- Stochastic Oscillator
- BRT 35.71
- SMTI 27.84
About BRT BRT Apartments Corp. (MD)
BRT Apartments Corp is a real estate investment trust company. The company is focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.